| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medical Nutrition Karolinska Institute Huddinge University Hospital, Novum F60 SE-141 86 Huddinge, Sweden
Glucocorticoids exert antiproliferative effects on a number of cell types, including the HeLa cervical carcinoma cell line. However, the mechanism responsible for the antiproliferative effect is poorly understood. In this report we have investigated the role of the recently identified cyclin-dependent kinase inhibitor (CDI) p57Kip2 in the antiproliferative effect conferred by glucocorticoids. When HeLa cells were treated with the synthetic glucocorticoid dexamethasone (DEX), the doubling time of exponentially growing cells increased 2-fold. Within 11 h of DEX treatment, this was accompanied by an accumulation of cells in the G1 phase of the cell cycle with a corresponding decreased proportion of cells in the S phase and decreased CDK2 activity. DEX treatment of the HeLa cells dramatically induced the protein and mRNA expression of the CDI p57Kip2. This induction was seen within 4 h of DEX treatment, preceding a major DEX-induced accumulation of cells in the G1 phase. DEX-induced mRNA expression of p57Kip2 did not require de novo protein synthesis, and the transcription of the p57Kip2 gene was increased as determined by a run-on transcription assay. Furthermore, DEX induction of p57Kip2 was not a consequence of the cell cycle arrest, since other growth inhibition signals did not result in strong p57Kip2 induction. Overexpression of p57Kip2 using HeLa cells stably transfected with a tetracycline-inducible vector showed that p57Kip2 is sufficient to reconstitute an antiproliferative effect similar to that seen in DEX-treated cells. Selective p57Kip2 expression by the tetracycline analog doxycycline to levels comparable to those observed on DEX induction resulted in a 1.7-fold increase in the doubling time and a shift of HeLa cells to the G1 phase as well as a decrease in CDK2 activity. Taken together, these results suggest that glucocorticoid treatment directly induces transcription of the p57Kip2 gene and that the p57Kip2 protein is involved in the glucocorticoid-induced antiproliferative effect.
This article has been cited by other articles:
![]() |
Y.-K. Kim, J. Yu, T. S. Han, S.-Y. Park, B. Namkoong, D. H. Kim, K. Hur, M.-W. Yoo, H.-J. Lee, H.-K. Yang, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer Nucleic Acids Res., April 1, 2009; 37(5): 1672 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Jin, Y. Lho, Y. Wang, M. Ao, M. P. Revelo, S. W. Hayward, M. L. Wills, S. K. Logan, P. Zhang, and R. J. Matusik Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse Cancer Res., May 15, 2008; 68(10): 3601 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kaur, J. E. Chivers, M. A. Giembycz, and R. Newton Long-Acting 2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells Mol. Pharmacol., January 1, 2008; 73(1): 203 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C Dhulipala, W. V Welshons, and C. S Reddy Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review Human and Experimental Toxicology, November 1, 2006; 25(11): 675 - 682. [Abstract] [PDF] |
||||
![]() |
G. Rothschild, X. Zhao, A. Iavarone, and A. Lasorella E Proteins and Id2 Converge on p57Kip2 To Regulate Cell Cycle in Neural Cells. Mol. Cell. Biol., June 1, 2006; 26(11): 4351 - 4361. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Bladh, J. Liden, A. Pazirandeh, I. Rafter, K. Dahlman-Wright, S. Nilsson, and S. Okret Identification of Target Genes Involved in the Antiproliferative Effect of Glucocorticoids Reveals a Role for Nuclear Factor-{kappa}B Repression Mol. Endocrinol., March 1, 2005; 19(3): 632 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamura, T. Hara, S. Kotoshiba, M. Yada, N. Ishida, H. Imaki, S. Hatakeyama, K. Nakayama, and K. I. Nakayama Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation PNAS, September 2, 2003; 100(18): 10231 - 10236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Consten, E.D. Keuning, J. Bogerd, M.A. Zandbergen, J.G.D. Lambert, J. Komen, and H.J.Th. Goos Sex Steroids and Their Involvement in the Cortisol-Induced Inhibition of Pubertal Development in Male Common Carp, Cyprinus carpio L Biol Reprod, August 1, 2002; 67(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Almawi and O. K. Melemedjian Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor J. Leukoc. Biol., January 1, 2002; 71(1): 9 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. RABBITT, G. G. LAVERY, E. A. WALKER, M. S. COOPER, P. M. STEWART, and M. HEWISON Prereceptor regulation of glucocorticoid action by 11{beta}-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation FASEB J, January 1, 2002; 16(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishimura, N. Nonomura, E. Satoh, Y. Harada, M. Nakayama, T. Tokizane, T. Fukui, Y. Ono, H. Inoue, M. Shin, et al. Potential Mechanism for the Effects of Dexamethasone on Growth of Androgen-Independent Prostate Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1739 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Shah, J. A. Iniguez-Lluhi, A. Romanelli, S. R. Kimball, and L. S. Jefferson The Activated Glucocorticoid Receptor Modulates Presumptive Autoregulation of Ribosomal Protein S6 Protein Kinase, p70 S6K J. Biol. Chem., January 18, 2002; 277(4): 2525 - 2533. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |